OBJECTIVES: The left atrium is a validated marker of clinical and subclinical cardiovascular disease. Left atrial enlargement is often seen among older individuals; however, there are few population-based data regarding normal left atrial size among older persons, especially from those who are healthy, and from women. Furthermore, because the left atrium is a 3D structure, the commonly used parasternal long-axis diastolic diameter often underdiagnoses left atrial enlargement.
METHODS: We evaluated left atrial size in 230 healthy participants (mean age, 76±5 years) free of prevalent cardiac disease, rhythm abnormality, hypertension, and diabetes selected from the Cardiovascular Health Study, a prospective community-based study of risk factors for cardiovascular disease in 5888 elderly participants. In addition to the standard long-axis measurement, we obtained left atrial superoinferior and lateral diameters and used these dimensions to estimate left atrial volume. These measurements were used to generate reference ranges for determining left atrial enlargement in older men and women, based on the 95% percentiles of the left atrial dimensions in healthy participants, both unadjusted, and after adjustment for age, height, and weight.
RESULTS: In healthy elderly subjects, indices of left atrial size do not correlate with age or height but with weight and other measures of body build.
CONCLUSIONS: These data provide normative reference values for left atrial size in healthy older women and men. The results should be useful for refining diagnostic criteria for left atrial dilation in the older population and may be relevant for cardiovascular risk stratification.
Department of Cardiology
Cleveland Clinic Florida
Latest posts by Gian Novaro (see all)
- Assessment of Post-Procedural Aortic Regurgitation After TAVR: An Intraprocedural TEE Study - September 24, 2015
- Assessment of the Radiation Effects of Cardiac CT Angiography Using Protein and Genetic Biomarkers - August 11, 2015
- Association of Left Ventricular Strain With 30-Day Mortality and Readmission in Patients With Heart Failure - June 20, 2015